nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—ACSL3—Fatty Acid Beta Oxidation—CHKB—narcolepsy	0.065	0.0979	CbGpPWpGaD
Icosapent—ACSL4—Fatty Acid Beta Oxidation—CHKB—narcolepsy	0.0493	0.0742	CbGpPWpGaD
Icosapent—ACSL3—Fatty Acid Beta Oxidation—CPT1B—narcolepsy	0.0442	0.0666	CbGpPWpGaD
Icosapent—PPARD—Import of palmitoyl-CoA into the mitochondrial matrix—CPT1B—narcolepsy	0.0406	0.0612	CbGpPWpGaD
Icosapent—ACSL3—forebrain—narcolepsy	0.0394	0.117	CbGeAlD
Icosapent—ACSL4—Fatty Acid Beta Oxidation—CPT1B—narcolepsy	0.0335	0.0504	CbGpPWpGaD
Icosapent—SLC8A1—forebrain—narcolepsy	0.0327	0.0972	CbGeAlD
Icosapent—FABP7—brainstem—narcolepsy	0.0249	0.0741	CbGeAlD
Icosapent—FABP7—forebrain—narcolepsy	0.024	0.0715	CbGeAlD
Icosapent—ACSL4—forebrain—narcolepsy	0.0198	0.0589	CbGeAlD
Icosapent—PPARD—forebrain—narcolepsy	0.019	0.0566	CbGeAlD
Icosapent—ACSL3—brain—narcolepsy	0.0164	0.0487	CbGeAlD
Icosapent—FADS1—medulla oblongata—narcolepsy	0.0158	0.0469	CbGeAlD
Icosapent—FADS1—midbrain—narcolepsy	0.0144	0.0428	CbGeAlD
Icosapent—ACSL4—medulla oblongata—narcolepsy	0.0143	0.0426	CbGeAlD
Icosapent—SLC8A1—brain—narcolepsy	0.0136	0.0403	CbGeAlD
Icosapent—ACSL4—midbrain—narcolepsy	0.0131	0.0389	CbGeAlD
Icosapent—PPARD—midbrain—narcolepsy	0.0126	0.0373	CbGeAlD
Icosapent—ACSL3—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.0116	0.0175	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0111	0.0167	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0111	0.0167	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0107	0.0161	CbGpPWpGaD
Icosapent—PPARD—Ectoderm Differentiation—SOCS2—narcolepsy	0.0101	0.0153	CbGpPWpGaD
Icosapent—FABP7—brain—narcolepsy	0.00997	0.0297	CbGeAlD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00992	0.0149	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00992	0.0149	CbGpPWpGaD
Icosapent—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00976	0.0147	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00958	0.0144	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—HCRT—narcolepsy	0.00911	0.0137	CbGpPWpGaD
Icosapent—FADS1—brain—narcolepsy	0.00905	0.0269	CbGeAlD
Icosapent—TRPV1—brain—narcolepsy	0.00905	0.0269	CbGeAlD
Icosapent—PPARG—forebrain—narcolepsy	0.00891	0.0265	CbGeAlD
Icosapent—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00883	0.0133	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00857	0.0129	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00857	0.0129	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00828	0.0125	CbGpPWpGaD
Icosapent—ACSL4—brain—narcolepsy	0.00821	0.0244	CbGeAlD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00815	0.0123	CbGpPWpGaD
Icosapent—PPARD—brain—narcolepsy	0.00789	0.0235	CbGeAlD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00735	0.0111	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00735	0.0111	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00709	0.0107	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—TRH—narcolepsy	0.0069	0.0104	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00682	0.0103	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00617	0.0093	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00603	0.00908	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00572	0.00861	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HCRTR2—narcolepsy	0.00559	0.00842	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HCRTR1—narcolepsy	0.00559	0.00842	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—P2RY11—narcolepsy	0.0054	0.00814	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00538	0.0081	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00517	0.00779	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—NPS—narcolepsy	0.00502	0.00755	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—TAC1—narcolepsy	0.00502	0.00755	CbGpPWpGaD
Icosapent—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00496	0.00747	CbGpPWpGaD
Icosapent—PTGS1—forebrain—narcolepsy	0.00476	0.0142	CbGeAlD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00468	0.00705	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00464	0.00699	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HCRT—narcolepsy	0.00459	0.00692	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00457	0.00689	CbGpPWpGaD
Icosapent—PTGS2—forebrain—narcolepsy	0.00455	0.0135	CbGeAlD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00449	0.00676	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00449	0.00676	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—PENK—narcolepsy	0.00409	0.00617	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00401	0.00604	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00389	0.00586	CbGpPWpGaD
Icosapent—PPARG—brain—narcolepsy	0.0037	0.011	CbGeAlD
Icosapent—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—narcolepsy	0.00353	0.00532	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00352	0.0053	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—TRH—narcolepsy	0.00348	0.00524	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00332	0.005	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00332	0.005	CbGpPWpGaD
Icosapent—PTGS2—medulla oblongata—narcolepsy	0.00329	0.00978	CbGeAlD
Icosapent—PPARG—Circadian rythm related genes—HCRTR1—narcolepsy	0.00321	0.00484	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—HCRTR2—narcolepsy	0.00321	0.00484	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00316	0.00476	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00316	0.00476	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—P2RY11—narcolepsy	0.00305	0.0046	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HRH3—narcolepsy	0.00305	0.0046	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—CHKB—narcolepsy	0.00304	0.00458	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00302	0.00454	CbGpPWpGaD
Icosapent—PTGS2—midbrain—narcolepsy	0.00301	0.00894	CbGeAlD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00291	0.00438	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HCRTR2—narcolepsy	0.00287	0.00432	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HCRTR1—narcolepsy	0.00287	0.00432	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—P2RY11—narcolepsy	0.00277	0.00418	CbGpPWpGaD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00271	0.00408	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0027	0.00406	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HCRT—narcolepsy	0.0026	0.00391	CbGpPWpGaD
Icosapent—FADS1—Metabolism—CHKB—narcolepsy	0.00255	0.00384	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—NPS—narcolepsy	0.00253	0.00381	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—TAC1—narcolepsy	0.00253	0.00381	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HCRT—narcolepsy	0.00236	0.00355	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00233	0.00351	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—PENK—narcolepsy	0.00231	0.00348	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CHKB—narcolepsy	0.0023	0.00347	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CHKB—narcolepsy	0.0023	0.00347	CbGpPWpGaD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—TNF—narcolepsy	0.00221	0.00332	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—PENK—narcolepsy	0.0021	0.00316	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—CPT1B—narcolepsy	0.00207	0.00311	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.002	0.00301	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00198	0.00298	CbGpPWpGaD
Icosapent—PTGS1—brain—narcolepsy	0.00198	0.00588	CbGeAlD
Icosapent—FFAR1—GPCR downstream signaling—TRH—narcolepsy	0.00197	0.00296	CbGpPWpGaD
Icosapent—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—narcolepsy	0.00193	0.00291	CbGpPWpGaD
Icosapent—PTGS2—brain—narcolepsy	0.00189	0.00562	CbGeAlD
Icosapent—PPARD—Gene Expression—CTNNBL1—narcolepsy	0.00187	0.00281	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—TRH—narcolepsy	0.00179	0.00269	CbGpPWpGaD
Icosapent—PTGS1—Overview of nanoparticle effects—TNF—narcolepsy	0.00174	0.00262	CbGpPWpGaD
Icosapent—FADS1—Metabolism—CPT1B—narcolepsy	0.00173	0.00261	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HRH3—narcolepsy	0.00172	0.0026	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HCRTR2—narcolepsy	0.0017	0.00255	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HCRTR1—narcolepsy	0.0017	0.00255	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—P2RY11—narcolepsy	0.00164	0.00247	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00159	0.00239	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HRH3—narcolepsy	0.00157	0.00236	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CPT1B—narcolepsy	0.00157	0.00236	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CPT1B—narcolepsy	0.00157	0.00236	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HTR2A—narcolepsy	0.00152	0.00229	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—NPS—narcolepsy	0.00145	0.00219	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—NPS—narcolepsy	0.00143	0.00215	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—TAC1—narcolepsy	0.00143	0.00215	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HCRT—narcolepsy	0.00139	0.0021	CbGpPWpGaD
Icosapent—PTGS2—Overview of nanoparticle effects—TNF—narcolepsy	0.00138	0.00208	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—TAC1—narcolepsy	0.0013	0.00195	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—NPS—narcolepsy	0.0013	0.00195	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CHKB—narcolepsy	0.00129	0.00195	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PENK—narcolepsy	0.00124	0.00187	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.00114	0.00172	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00111	0.00167	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00108	0.00163	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TRH—narcolepsy	0.00106	0.00159	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—CTNNBL1—narcolepsy	0.00102	0.00154	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—TNF—narcolepsy	0.000975	0.00147	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRH3—narcolepsy	0.000925	0.00139	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000883	0.00133	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CPT1B—narcolepsy	0.00088	0.00133	CbGpPWpGaD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—TNF—narcolepsy	0.000874	0.00132	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HTR2A—narcolepsy	0.00086	0.0013	CbGpPWpGaD
Icosapent—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—narcolepsy	0.00081	0.00122	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HTR2A—narcolepsy	0.000781	0.00118	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NPS—narcolepsy	0.000767	0.00115	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TAC1—narcolepsy	0.000767	0.00115	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000756	0.00114	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CHKB—narcolepsy	0.000707	0.00106	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00068	0.00102	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.000636	0.000958	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0006	0.000904	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—TNF—narcolepsy	0.000533	0.000802	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—TNF—narcolepsy	0.00051	0.000768	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CHKB—narcolepsy	0.000495	0.000746	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CPT1B—narcolepsy	0.000481	0.000724	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HTR2A—narcolepsy	0.000461	0.000695	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—TNF—narcolepsy	0.000405	0.00061	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CHKB—narcolepsy	0.000393	0.000592	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CPT1B—narcolepsy	0.000337	0.000507	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TNF—narcolepsy	0.00032	0.000482	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CPT1B—narcolepsy	0.000267	0.000402	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000218	0.000328	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—narcolepsy	0.000183	0.000276	CbGpPWpGaD
